SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Araceli Biosciences launches Endeavor high content analysis platform

Araceli Biosciences
19 Mar 2021
Tom Casburn
Associate Editor

Product news

Araceli Biosciences, a provider of advanced biological imaging platforms, announced the launch of its flagship product, the Araceli Endeavor™. Endeavor revolutionizes drug discovery by delivering high speed, high resolution, full well scanning of cell-based assays.

Endeavor images 10 times the biology in a fraction of the time, acquiring every cell, every time. Endeavor combines exceptionally fast, full well imaging with sub-half micron pixel resolution, generating high quality, high-resolution data.

With no training required, the Araceli platform makes high content analysis comprehensive, fast and easy. With intelligent tools users can generate quality results quickly and confidently, reducing the time needed for drug discovery. A single Endeavor system can acquire over 20,000 complete wells per day, at a market-leading rate of 480 megapixels/second.

“The role of high content analysis in drug discovery has unfortunately been limited in the last 20 years due to throughput,” says Jeff Harris, General Manager of Araceli Biosciences. “It just hasn’t been fast enough. We set out to change that.”

“We are very excited to release Endeavor and address a tremendous need in the drug discovery space,” says Maggie Vantangoli Policelli, Ph.D. “For far too long, high content analysis has meant compromise – sacrificing either speed or sample coverage. Now Endeavor collects ultra-high-resolution data of every cell quickly. It is a game-changer – with high-resolution full-well imaging, you can see more biology than ever before, faster than ever before.”

For more of the latest science news, straight to your inbox, become a member of SelectScience for free today>>

Links

Araceli BiosciencesCompany website

Tags

Microarray AnalysisMicroarrays, also known as biochips, are used for the detection and analysis of multiple genes, proteins, antibodies, or biomarkers on a single microchip. This can reveal information on protein or gene expression, single nucleotide polymorphism (SNP), copy number variation (CNV), epigenetics and patient health in clinical diagnostic tests. Discover a range of microarray scanners and prefabricated antibody, protein, RNA and DNA microarrays for your analysis or consider creating your own custom microarrays with a microarray printer. Find the best microarray products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.High-Content ScreeningHigh-content screening (HCS), also known as high-content analysis (HCA), is a high-throughput technique used in drug discovery to identify substances that alter the phenotype of cells. HCS uses fluorescent microscopic imaging and automated image analysis to investigate cellular events such as apoptosis, cell viability, GPCR activation, oxide production, neurite outgrowth, and cell signaling. Find the best fluorescent labeling reagents, cellular assays, and high-content imaging systems in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.Cell AnalysisThe analysis of cells allows researchers to understand the factors which contribute to cell health and function. These influencing processes can then be predicted and altered, leading to the development of medication and disease treatments.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.

Related articles

Araceli Biosciences launches Endeavor high content analysis platform